7 results
Keyword Evusheld Remove keyword
Type of content
News Remove News filter
Categories
Human Remove Human filter
-
List item
News: EMA recommends authorisation of COVID-19 medicine Evusheld
CHMP, Last updated: 24/03/2022authorisation of COVID-19 medicine Evusheld … marketing authorisation for Evusheld, developed by AstraZeneca … to the SARS-CoV-2 virus. Evusheld is made of the The substance … -
List item
News: EMA starts rolling review of Evusheld (tixagevimab and cilgavimab)
CHMP, Last updated: 14/10/2021EMA starts rolling review of Evusheld (tixagevimab and cilgavimab … EMA starts rolling review of Evusheld (tixagevimab and cilgavimab … -
List item
News: ETF warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-2
Last updated: 09/12/2022body’s cells. These are Evusheld (tixagevimab / cilgavimab … course. References: 1: Evusheld EPAR Evusheld | European Medicines Agency … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 March 2022
CHMP, Last updated: 25/03/2022Evusheld … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022
CHMP, Last updated: 19/09/2022Evusheld … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2022
PRAC, Last updated: 10/06/2022 -
List item
News: EMA adopts first list of critical medicines for COVID-19
Last updated: 08/06/2022Oral, Parenteral All Evusheld Tixagevimab/Cilgavimab Tixagevimab/Cilgavimab …